Metformin therapy modifies corneal neuroimmune abnormalities in people with type 2 diabetes
Tsoi AT, Sng J, Tummanapalli SS, et al.
Diabetologia. Pub. online 7 Mar 2025.
Leggi
Multivitamins after myocardial infarction in patients with diabetes: a randomized clinical trial
Ujueta F, Lamas GA, Anstrom KJ, et al.
JAMA Intern Med. 2025:e248408.
Leggi
The impact of sodium-glucose cotransporter-2 inhibitors on atrial fibrillation burden in diabetic patients
Kidess GG, Hamza M, Goru R, et al.
Am J Cardiol. Pub. online 7 Mar 2025.
Leggi
OCCHIO AL TRIAL AMD: DOPPIO APPUNTAMENTO 20 E 27 MARZO
Carissimi Soci, doppio appuntamento a marzo con gli approfondimenti Occhio al Trial AMD. Ci troveremo il 20 e il 27 marzo alle ore 18.00 per due nuove dirette: 20.03 "MAESTRO-NASH: il trial di fase 3 che consacra il Resmetirom come primo trattamento per la steatoepatite associata a disfunzione metabolica" Angelo…
Leggi
AIFA: Una App a semaforo targata AIFA per favorire l’uso appropriato degli antibiotici
04/03/2025
Leggi
Continuous glucose monitoring-based titration of once-weekly insulin icodec in insulin-naive individuals with type 2 diabetes (ONWARDS 9): a phase 3b, multicenter, single-arm, treat-to-target clinical trial
Bergenstal RM, Ásbjörnsdóttir B, Johanning Bari T, et al.
Diabetes Technol Ther. Pub. online 5 Mar 2025.
Leggi
Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
GBD 2021 Adolescent BMI Collaborators: Kerr JA, Patton GC, Cini KI, et al.
Lancet. 2025:S0140-6736(25)00397-6
Leggi
Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
GBD 2021 Adult BMI Collaborators: Ng M, Gakidou E, Lo J, et al.
Lancet. 2025:S0140-6736(25)00355-1.
Leggi